NR-50348大肠杆菌-金黄色葡萄球菌穿梭载体pKK22,在大肠杆菌中重组(质粒/载体)
NR-50348 is a preserved culture of Escherichia coli (E. coli) DH5αλpir containing the E. coli-staphylococcal shuttle vector pKK22. Vector pKK22 contains the E. coli R6Kγ origin of replication and is for use in E. coli and Staphylococcus aureus (S. aureus) USA300 strains that contain LAC-p01, rendering them isogenic. Vector pKK22 contains a single trimethoprim resistance cassette that is functional in both E. coli and S. aureus. The complete pKK22 nucleotide sequence is available (GenBank: KX085042) and the vector map of pKK22 is available on the Product Information Sheet.
pKK22 was deposited in conjunction with pKK30 and E. coli strains DH5αλpir and GM2163λpir (available as a kit, BEI Resources NR-50352). pKK22 and pKK30 were created to maintain stability in E. coli and Staphylococcus species without antibiotic selection during in vitro and in vivo experiments. The E. coli R6Kγ origin of replication of both vectors requires pir+ for replication which is provided in either DH5αλpir or GM2163λpir E. coli strains.
NR-50348 | pKK22 | For use in E. coli DH5αλpir or GM2163λpir or S. sureus USA300 strains containing LAC-p01 |
NR-50349 | pKK30 | pKK30 is a variant of pKK22, for use in E. coli DH5αλpir or GM2163λpir or Staphylococcus species not containing LAC-p01 |
NR-50350 | E. coli DH5αλpir | Host strain containing the pir genes for performing genetic manipulations prior to transfer into Staphylococcus (F-?80dlacZ ΔM15 ΔlacZYA-argF U169 deoR supE44 hsdR17 recA1 endA1 gyrA96 thi-1 relA1) |
NR-50351 | E. coli GM2163λpir | Host strain containing the pir genes for performing genetic manipulations. This strain is also a dam and dcm methylase mutant for transfer of plasmids into Staphylococcus isolates that do not accept E. coli DNA easily (F-ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 hisG4 rfbD1 rpsL136 dam13::Tn9 xylA5 mtl-1 thi-1 mcrB1 hsdR2 λpir) |
This strain was developed by Krute, et al., at the Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, PubMed: 27637878.
Each vial of NR-50348 contains approximately 0.5 mL of E. coli, DH5αλpir, in Tryptic Soy broth containing 10 ?g/mL trimethoprim supplemented with 10% glycerol.
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。